effects of Carboblocker on weight loss in obese or overweight adults

effects of Carboblocker (Combination of famous vulgaris and chromium picolinate) compared to placebo on weight loss in obese or overweight adults

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140804018677N22

Enrollment

Registered

2022-07-22

Start date

2022-07-11

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity. Overweight and obesity

Interventions

Intervention 1: Intervention group: The duration of intervention in this clinical trial will be 8 weeks. Beside calorie restricted diet (300-500 Kcal less than calculated daily energy need) people wi

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Body mass index of 25-40 age of 16-65years Willing to participate

Exclusion criteria

Exclusion criteria: Consuming weight reduction medications substance overuse Pregnancy and lactation Having known kidney disease Having known heart disease

Design outcomes

Primary

Measure	Time frame
Weight. Timepoint: Baseline and after 2 months from the beginning of the study. Method of measurement: Scale.	—

Secondary

Measure	Time frame
Fat mass. Timepoint: Baseline and after 2 months from the beginning of the study. Method of measurement: Omron BF511 body composition scale.;Fat free mass. Timepoint: Baseline and after 2 months from the beginning of the study. Method of measurement: Omron BF511 body composition scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoodeh Razghei Jahromi

Shahid Beheshti University of Medical Sciences

soodehrazeghi@gmail.com+98 21 2235 7483

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026